MetLife Investment Management’s Lifestance Health LFST Stock Holding History

MetLife Investment Management’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Buy	112,371 +23,348	+26%	+$180K	0.01%	1429
2026 Q1	$567K	Sell	89,023 -3,916	-4%	-$27.2K	﹤0.01%	1688
2025 Q4	$654K	Buy	92,939 +13,000	+16%	+$78.4K	﹤0.01%	1667
2025 Q3	$440K	Sell	79,939 -4,623	-5%	-$22.7K	﹤0.01%	1867
2025 Q2	$437K	Hold	84,562	–	–	﹤0.01%	1739
2025 Q1	$563K	Sell	84,562 -1,352	-2%	-$10.3K	﹤0.01%	1672
2024 Q4	$633K	Buy	85,914 +5,492	+7%	+$39.4K	﹤0.01%	1671
2024 Q3	$563K	Buy	80,422 +10,084	+14%	+$60.6K	﹤0.01%	1724
2024 Q2	$345K	Buy	70,338 +13,731	+24%	+$82.8K	﹤0.01%	1932
2024 Q1	$349K	Hold	56,607	–	–	﹤0.01%	1881
2023 Q4	$443K	Hold	56,607	–	–	﹤0.01%	1763
2023 Q3	$389K	Hold	56,607	–	–	﹤0.01%	1787
2023 Q2	$517K	Buy	56,607 +14,541	+35%	+$121K	﹤0.01%	1670
2023 Q1	$313K	Hold	42,066	–	–	﹤0.01%	1932
2022 Q4	$208K	Hold	42,066	–	–	﹤0.01%	2226
2022 Q3	$278K	Hold	42,066	–	–	﹤0.01%	2076
2022 Q2	$234K	Hold	42,066	–	–	﹤0.01%	2203
2022 Q1	$425K	Buy	42,066 +24,446	+139%	+$215K	﹤0.01%	1870
2021 Q4	$168K	Hold	17,620	–	–	﹤0.01%	2169
2021 Q3	$255K	Buy	+17,620	New	+$339K	﹤0.01%	1931

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

MetLife Investment Management's LFST Position: Q2 2026 in Review

MetLife Investment Management increased its Lifestance Health (LFST) stake by 26% in Q2 2026, buying an estimated $180K and bringing the position to 112,371 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #1429.

MetLife Investment Management first reported a position in LFST in Q3 2021 and has held it in 20 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

MetLife Investment Management held 112,371 shares of Lifestance Health worth $1.2M as of Q2 2026.
MetLife Investment Management bought 23,348 Lifestance Health shares in Q2 2026, an estimated $180K.
Lifestance Health made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1429 holding.
MetLife Investment Management first reported a position in Lifestance Health in Q3 2021 and has held it in 20 quarters since.
288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.